chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red, itchy rash/on her chest and spread to her head, neck, ears and back. It also spread in a smaller amount to her arm, wrists, legs and ankles; Welts/Hives; burst blood vessel in her eye; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in arm left on 07Oct2021 at 15:00 (Lot Number: 301568A) as dose 2, single (at the age of 52 years old) for COVID-19 immunization. Medical history included celiac, hypothyroid from 08Jan2017 and ongoing, "adrenal insuff" from 01Aug2020 and ongoing, menopause from 01Nov2018 to an unknown date, seasonal affective disorder (SAD)/anxiety from 01Nov2018 and ongoing. Concomitant medications included levothyroxine sodium (SYNTHROID) taken for thyroid from 08Jan2017 and ongoing; liothyronine sodium (CYTOMEL) taken for thyroid from 08Jan2017 and ongoing; bupropion hydrochloride (WELLBUTRIN) taken for SAD/Anxiety from 01Nov2018 and ongoing; hydrocortisone taken for adrenal insuff from 01Aug2020 and ongoing; progesterone taken for menopause from 01Nov2018 and ongoing. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via intramuscular administered in left arm on 16Sep2021 at 11:00 AM (however also reported as 2100) as dose 1 (at the age of 52 years old) for COVID-19 immunization; gluten and experienced allergy. No other vaccine in four weeks/ No Prior vaccinations (within 4 weeks). No COVID prior vaccination. On 18Oct2021 at 12:00 AM, about 10 days after second dose, the patient developed a red, itchy rash. It started on her chest and spread to her head, neck, ears and back. It also spread in a smaller amount to her arm, wrists, legs and ankles. The patient's 2nd vaccine was taken (as recommended) 3 week after her 1st-on 07Oct2021. On 09Oct2021, she woke up with a burst blood vessel in her eye, she had never had one before. It looked awful, but it didn't hurt. Around 16Oct2021, she developed a red itchy rash on her neck plus chest. It spread to her head, face, ears and back. There were welts, hives, red bumps, etc. Her wrists and ankles got small red, itchy dots on them, her ears and chest were hot, itchy and sore. After a few days, it got a little better with ibuprofen and cold compresses. Then it flared up again. She went to a quick care facility and was given a steroid shot, pills and creme to treat a severe allergic reaction. After 10 days, she got a refill because it was still red plus itchy, but not as bad as before she went to the Doctor. The patient underwent lab tests and procedures which included Covid-19: negative on 17Oct2021 and on 29Oct2021, Nasal Swab: negative on 16Oct2021. Therapeutic measures were taken as a result of the events. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
Within 2 hours started itching from head to toe. Inside ears, back, everywhere.  My skin is sensitive so I saw mild hive like rash but it was very faint.
Persistent swollen Eustachian tubes.  Excessive wax build up in ears. Fluid dripping from ears.  Continuing for 4+ months
Patient complained of tickle in throat, feeling warm and sensation of throat swelling. Place patient in recumbent position and administered epi pen. Paramedics called. Patient denied throat swelling after epi pen was administered.
Felt no energy & unusually tired  and slight chills  then had fever of  average of  101.6 thru out the day and into the evening. No appetite all day.  Worked thru it but wrapped up under blankets and took a nap for approximately 3 hrs and got up and Took  2 tylenol in evening  and it brought down the fever enough to give me an appetite and stop chills.  Still low energy.  lasted until next morning woke up back to normal energy etc.  NOTE:  Symptoms didn't start until12 - 24 hrs after the shot.
leg swelled to twice size;inconsolable crying x 8hr this occurred w/in 24hr of vax;
Chills and fever to 102 from Saturday 03/05 to Monday 4:00 on 03/08 with headache and extreme fatigue.  Left arm hot and swollen and painful to touch.
Soreness in injection site muscle; significant fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021(at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma (predisposition to walking pneumonia). The patient did not have any allergies to medications, food, or other products. Concomitant medications included naproxen sodium (ALEVE) which was taken 1 week prior, on an unknown date and for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 30Mar2021 the patient experienced soreness in injection site muscle (vaccination site pain) and significant fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse event.  The clinical outcome of the event soreness in injection site muscle (vaccination site pain) and significant fatigue was recovered on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Vaccinated with shaken vaccine; pain at the injection site; A spontaneous report  was received from a pharmacist concerning a 57-year-old, male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced vaccine that was shaken and pain at the injection site.   The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.    The patient received their first of two planned doses of mRNA-1273 on an undisclosed date intramuscularly for prophylaxis of COVID-19 infection.  On 04 Jan 2021, the reporter stated that  on a undisclosed date, the technician shook the vial while administering the vaccine to the patient. They also reported that symptoms included pain at the injection site.  No treatment information was provided  Action taken with mRNA-1273 in response to the events, the technician shook the vial while administering the vaccine and pain at the injection site, was not provided.   The events, the technician shook the vial while administering the vaccine was considered recovered/resolved.   The outcome of the events, pain at the injection site was not reported.; Reporter's Comments: This case concerns a 57-year-old  male patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Out of specification product use and Injection site pain.  Based on the known safety profile and temporal association between vaccination and onset of the event, a causal relationship cannot be excluded, and the event Injection site pain is considered possibly related to the vaccine.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-002858: US-MODERNATX, INC.-MOD-2021-002848: US-MODERNATX, INC.-MOD-2021-002872:
Patient came into pharmacy with rash on his left arm that was seeping and red. He received the shingles shot on 9/26/16. Patient may have the shingles.
Complex febrile seizures-1 episode generalized tonic clonic seizure lasting approximately 35 min associated vesculated rash all over. Review of hospital records. Please add INJURY ACCID, RHINITIS, and DYSPNEA.
No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Tired). On 01-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the Touch Injection Site), VACCINATION SITE REACTION (Reaction on the Injection Site Left Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE PAIN (Hurt Injection Site) and VACCINATION SITE RASH (Rash Injection Site Left Arm (Oval shape 3'X4")). On 02-Mar-2021, the patient experienced PAIN (Real Achy all over the body). On 09-Mar-2021, the patient experienced MYALGIA (Muscle Aches). On 01-Mar-2021, FATIGUE (Tired) had resolved. At the time of the report, PAIN (Real Achy all over the body), VACCINATION SITE WARMTH (Warm to the Touch Injection Site), VACCINATION SITE REACTION (Reaction on the Injection Site Left Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE PAIN (Hurt Injection Site), VACCINATION SITE RASH (Rash Injection Site Left Arm (Oval shape 3'X4")) and MYALGIA (Muscle Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
sore injection site next day.  2 days later started feeling sick, headache, chills and upset stomach, patient has been feeling worse with fever and wanting to vomit and aching all over.  Each day goes by he feels worse, Called Doctors office let the nurse know he is not feeling well, no response back yet.
This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender. No pertinent medical history was reported. On 29-JUL-2015, the patient was vaccinated with PROQUAD INJ (Merck) (lot # K020752 and expiration date 30-APR-2016) (strength, dose and route were not reported) which was improperly stored. No adverse events were reported. This is one of the two reports received from the same source. Additional information has been requested.
Said felt lightheaded/warm and nauseous immediately after vaccination, felt better after approximately 10 min. Did not actually faint.
Information has been received on 15-AUG-2016 from a 76 year old male consumer. The patient's medical history and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX. On 14-MAR-2016, the patient developed shingles. The patient had a rash on the right side of his face which affected his sight in the right eye and he lost 75% of his hearing in his right ear. The patient received unspecified treatment and an unspecified blood test was performed. The patient reported he recovered sometime within the last month. The patient reported that he saw a legal advertisement to obtain financial compensation for medical bills incurred for patients who developed shingles after receiving the vaccine. No further information was reported. Additional information has been requested.
Swollen face on left side and red bump on face  Red rash on left arm site of injection  Period went off prior to vaccine and now period has returned. This has never happened before.
ear pruritus in right ear, itchy skin just above affected ear on scalp, and skin behind affected ear and just under ear on throat/neck. All related mild and just a little annoying but I was advised to report it all the same.
Information has been received from a healthcare worker concerning a 65 year old female, with unknown medical history, history and unknown drug reactions/allergies, who on  04-APR-2006 was vaccinated (route unknown) with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine.  On 14-APR-2006 the patient experienced pain at the injection site, fever, chills and fatigue after receiving the vaccination.  The patient's status was reported as not recovered.  Unspecified medical attention was sought.  No product quality compliant was involved.  Additional information has been requested.
He got his vaccine, he just had a little arm pain and some stomach problems, but nothing much.  Then he noticed partial loss of taste and then Friday he was not able to close his eye and then went to the ER on Saturday has partial left sided facial paralysis, pain in his eye, drooling on the left side, and difficulty speaking.  He was diagnosed with Bell's palsy.  They gave him some steroid of Prednisone for 6 days and Valacyclovir for 7 days as well for treatment of this.  He has had no improvement in his symptoms yet.  Was told that it takes a minimum of at least 3 weeks.
Itchy raised red rash or bumps near the vaccination site. May not be related because they didn't show up until 7 days after the vaccination some time in the evening of January 24. As of today, January 26, they are still there. I am using hydrocortisone cream to treat and trying not to scratch.  The area is hot to the touch and a little bit hard. It's possible it's a bugbite, but doesn't look like on. I have not reported to my doctor yet, but will later today. There are no other symptoms and I was able to sleep last night and am at work today.
BP increased to 215/115 before I went to ER and then administered intravenous drugs and nitroglycerin cream over heart area.; This is a spontaneous report received from agency, This is a spontaneous report from a contactable consumer or other non-health care professional. A 51-years-old male patient received dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EP6955) via an unspecified route of administration and administered in left arm on 22Mar2021 12:30 as 1 st dose, single for COVID-19 immunization. The patient didnot receive any other vaccines within 4 weeks prior to the COVID vaccine and didnot have any allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination and since vaccination patient didnot test for COVID-19. The patient medical history includes border hypertension. The patients concomitant medication included lisinopril (LISINOPRIL) 20mg and it was other medications the patient received within 2 weeks of vaccination. The patient experienced increased in blood preasure to 215/115 before he went to Emergency room/department or urgent care on 22Mar2021 and then treated with intravenous drugs and nitroglycerin cream over heart area. The outcome of event was recovered.  No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a pharmacist refers to two patients of unknown age. The two patients were each administered an expired dose of PNEUMOVAX 23 (lot number of each dose: unknown; expiration date of each dose: 25-FEB-2012) intramuscularly on 14-JUL-2012. It was unknown if this was the first dose of PNEUMOVAX 23 for either patient. No adverse effect reported. It was unspecified if the patients had sought medical attention. Additional information has been requested.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Chills-Medium, Systemic: Tingling of Lips and Tongue-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium
PATIENT STARTED FEELING DIZZY AND SHE ALMOST FAINTED.MOM WAS HOLDING PATIENT.
Fainting spell after vaccination of Tdap, MCV4, FLUMIST and HPV. Without conscious loss. ADVIL given by mouth for pain and vital sign monitoring for 30 mins.
About 10 hours after immunizations, sat up in bed, said she wanted to eat somewhere. Also, whole body shaking for about 1 minute without loss of consciousness or fever not post-ictal.
Patient received HPV vaccine, then MCV4, and lastly the Tdap. Patient remained seated, as nurse was assessed how he was feeling. patient stated he felt fine, but then  fell forward onto  his lap. Nurse laid him back on to exam bed. Patient was alert with in a few seconds. Father stayed with patient while nurse asked provider to assess patient. Dr. assessed patient, and getting vitals. Instructed patient to drink at least 8 glasses of water today, some water and juice before leaving the clinic today. Patient drank water and juice then stood and walked while nurse observed. Patient and father felt confident that they were ready to go. patient left after15 minutes post syncope episode.
Hospitalized 12/13/2021; COVID-19 positive 12/13/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: (NAME), MD Primary Care Provider: (NAME), MD Admission Date: 12/13/2021 Discharge Date: Dec 15, 2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: DKA, type 1, not at goal (HCC) Diabetic ketoacidosis without coma associated with type 1 diabetes mellitus (HCC)  COVID-19    HOSPITAL COURSE: No notes on file 25 y.o. male with PMHx significant for T1DM who presents today with DKA. Pt is frequently admitted for DKA, most recent admission 11/5 with venous pH 6.89. Pt reports he has been again out of insulin with last dose of toujeo on 12/11 at 0500. He does not recall how many units he took. History is limited by frequently falling asleep in conversation. He is able to say he has not been feeling well for a couple of days with fatigue, abdominal pain, nausea, vomiting, polyuria, polydipsia and chest tightness. He denies SOB, cough, headache, dizziness, light headedness and changes to his mood.    With anion gap met acid on admission, admitted and started on IV insulin drip , and BMP monitoring. Readily closed anion gap, electrolytes corrected. Transitioned to Lantus and humalog and continued to do well. On further history taking, seem to have missed a dose, and that precipitated the DKA. His prescription sent to his pharmacy prior to discharge.   Incidentally found to be COVID + and was due for the booster next month. No fever chills, no dyspnea , no hypoxia, no diarrhea. Advised quarantine and observe for signs and symptoms to call PCP for.
Patient noted to develop complaints of chest and neck tightness approximately 5-6 minutes after flu shot, no known prior flu shot reactions, had associated tach apnea and respiratory distress, required albuterol 120 b x 2 with eventual improvement in symptoms, increase pulse flow from 150 to 370, 98% 02 Sat, negative EKG.
Palpable induration starting on day of injection that continues 4 months post injection. Afebrile. No symptoms from what we can tell given that patient is non-verbal.
today 3/4/2021 the day after my shot....at 11:30 am 3/4/2021....I noticed small red dots (rash) not many though. only on my legs at this point.  They itch but didn't know if I should take benardly ? I am waiting on my primary doctor to call me back....out to lunch unt 2 pm CT.
PATIENT PRESENTED TO OUR CLINIC WITH A LETTER STATING HE NEEDED HIS 2ND HEPATITIS A.  VACCINATION WAS GIVEN AND THEN DOCUMENTATION WAS DISCOVERED OF PREVIOUS #2 DOSE GIVEN 9/3/09.  NO ADVERSE REACTIONS NOTED TO CLIENT.
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. On 02-JAN-2015, the patient was vaccinated with M-M-R II (route, dose, frequency and lot # not reported) which underwent an excursion (on an unspecified date). This is one of several reports from the same source. Additional information has been requested.
6JUN96 @ 1653 mom notified clinic that pt may have chicken pox dx as having them
feeling extremely dizzy; I could not get the taste of food; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 03Mar2021 02:30 (Lot Number: EN6203) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. Medical history was reported as none. Patient had no allergies. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. On 03Mar2021, the patient was feeling extremely dizzy and could not get the taste of food the first two days. Patient was feeling less dizzy on  05Mar2021. No treatment was received for the events. At the time of report, the patient was recovering from the events.  No follow-up attempts are possible. No further information is expected.
Moderna COVID-19 Vaccine EUA: one day after vaccination fell and presented to emergency department (ED) with hypotension, fever, and dyspnea. Received antibiotics for community acquired pneumonia, physical and occupational therapy, wound care for laceration from fall, supportive care, and discharged to home medically stable.
Extreme soreness in arm within an hour after shot. Red at site of shot 12 hours later and radiating red around injection site 36 hours later.
Patient, report has cough listed. Only symptom charted. No pre-existing conditions listed   Tested positive for Covid 11/29/2021.  Died 01/20/2022
This spontaneous case was reported by a consumer and describes the occurrence of VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), PELVIC PAIN (Pain in her pelvis where tumor had been) and FEELING ABNORMAL (Feels cruddy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Acute myeloid leukaemia (11 years ago) and Tumor (Tumor in  pelvis). On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), LYMPHADENOPATHY (Glands are bigger (same side as vaccination)) and NAUSEA (Queasy/Nausea). On 14-May-2021, the patient experienced PELVIC PAIN (Pain in her pelvis where tumor had been). On 18-May-2021, the patient experienced FEELING ABNORMAL (Feels cruddy). On an unknown date, the patient experienced VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient). At the time of the report, VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), PELVIC PAIN (Pain in her pelvis where tumor had been), LYMPHADENOPATHY (Glands are bigger (same side as vaccination)) and NAUSEA (Queasy/Nausea) outcome was unknown and FEELING ABNORMAL (Feels cruddy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: inconclusive (Inconclusive) Vitamin B deficiency. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications were not reported. The treatment information was not provided. This case was linked to MOD-2021-228230. Most recent FOLLOW-UP information incorporated above includes: On 20-Jun-2021: The follow up document was received on 20-JUN-2021.